Navigation Links
BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors
Date:12/9/2009

different from any future results, performances or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: that the U.S. government and ex-U.S. governments may choose not to issue additional orders for peramivir and such orders, if any, may not be profitable for BioCryst; that to the extent peramivir is used as a treatment for H1N1 flu (or other strains of flu), there can be no assurance that it will prove effective; that HHS may further condition, reduce or eliminate future funding of the peramivir program; that ongoing peramivir clinical trials or our peramivir program in general may not be successful; that BioCryst or its licensees may not commence as expected additional human clinical trials with our product candidates; that our product candidates may not receive required regulatory clearances from the FDA; that ongoing and future pre-clinical and clinical development may not have positive results; that we or our licensees may not be able to continue future development of our current and future development programs; that our development programs and partnerships may never result in future product, license or royalty payments being received by BioCryst; that BioCryst may not be able to retain its current pharmaceutical and biotechnology partners for further development of its product candidates or it may not reach favorable agreements with potential pharmaceutical and biotechnology partners for further development of its product candidates; that our actual cash burn rate may not be consistent with our expectations; that BioCryst may not have sufficient cash to continue funding the development, manufacturing, marketing
'/>"/>
SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
2. BioCryst Provides Forodesine HCl Update
3. BioCryst Updates Peramivir Clinical Development Plan
4. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
5. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
6. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
7. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
8. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
9. BioCryst Provides Update Regarding Peramivir for Influenza
10. BioCryst Clarifies Government Declaration Regarding Peramivir
11. BioCryst to Present at JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... A hernia is condition in which ... the wall of a weak muscle area. Obesity, poor nutrition, ... of the causes of hernias. There are several types of ... inguinal hernia is when part of the abdominal tissue/organ protrudes ... the area of the umbilicus. A hiatal hernia is when ...
(Date:11/26/2014)... Calif. , Nov. 26, 2014  Aridis ... to produce novel therapies for infectious diseases, announced ... M.D., an internationally recognized key opinion leader in ... Company,s scientific advisory board. Founder and ... stated, "We believe Dr. Opal,s extensive experience investigating ...
(Date:11/26/2014)... November 25, 2014 According ... by Power Source (Electric, Battery, Pneumatic), by Product ... Burr, Cart), by Application (Orthopedic, ENT, Oral, Thoracic, ... MarketsandMarkets, the global Powered Surgical Instruments Market is estimated ... in 2014 and is expected to grow at ...
Breaking Medicine Technology:Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4
... 2011 At the ARPA-E Energy Innovation Summit today ... ) will announce significant progress towards developing economical, commercial ... power plants.  The program is supported by an ARPA-E ... emitters of carbon dioxide, a significant greenhouse gas. ...
... SAN ANTONIO, Feb. 28, 2011 Advanced Cell ... its clinical study utilizing RNAscope™ technology to detect ... specimens of head and neck cancer. HPV status ... predictive of patient outcome and highly concordant with ...
Cached Medicine Technology:Codexis Announces Carbon Capture Progress at ARPA-E Summit 2Codexis Announces Carbon Capture Progress at ARPA-E Summit 3ACD Announces Clinical Study Results Using its RNAscope™ Technology 2ACD Announces Clinical Study Results Using its RNAscope™ Technology 3
(Date:11/27/2014)... Randy Dotinga HealthDay Reporter ... brains seem pre-wired to acquire a second language, new research ... tongue will likely gain a brain boost, the small study ... after learning," said study co-author Ping Li, co-director of the ... But it,s even more interesting, Li said, that "the brain ...
(Date:11/27/2014)... The founders of VIM & VIGR, a company ... compression socks, are proud to announce the debut of their ... Pressure (TM) knitting technology that is designed to increase the ... to adding flair and style to a product that has ... eye of a writer at The New York Times ...
(Date:11/27/2014)... November 27, 2014 VogueQueen.com is making ... for ladies across the world. As the premier online ... VogueQueen.com is proud to release a huge selection of ... quality outfits, it is also providing many beautiful styles ... prom gowns at discounted prices. , “VogueQueen.com hopes ...
(Date:11/27/2014)... Dallas, Texas (PRWEB) November 27, 2014 ... research report on Global Insulin industry. For an ... including definition, classification, application, industry chain structure, industry ... report on global Insulin industry covers information ... manufacturing process, product cost structure and much more. ...
(Date:11/27/2014)... "The uglier, the better," says Dr. Kirk Kimmerling. ... laughter as we enjoy the ugly sweater contest." Last ... scratch. " It was a sight to see. She ... enough, the Christmas balls were faces of the staff with ... participating this year, it's simple to get in on the ...
Breaking Medicine News(10 mins):Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3
... in German . , On 7 ... in Health Care (IQWiG) published the results of a ... heart disease (CHD). The aim of the report is ... methodological quality that may be relevant for the planned ...
... undergoing radiation treatments for head and neck cancer fare ... according to a study in the February issue of ... official journal of the American Society for Radiation Oncology ... smoking and head and neck cancers has long been ...
... have discovered a novel function of brain insulin, indicating that ... unrestrained lipolysis that initiates and worsens type 2 diabetes in ... Cell Metabolism . Led by Christoph Buettner, MD, ... and Bone Disease at Mount Sinai School of Medicine, the ...
... HealthDay Reporter , TUESDAY, Feb. 15 (HealthDay News) -- ... they,re first tested may not need to be screened annually ... study suggests. Dutch researchers presenting the findings at ... men with a PSA below 3.0 ng/ml were likely to ...
... Feb. 15 (HealthDay News) -- Men with prostate cancer may be ... baldness at the age of 20 than those without prostate cancer, ... hair in their 30s or 40s do not appear to face ... loss starts in their 20s do not face a higher risk ...
... more likely to be readmitted to the hospital after a ... pneumonia, according to a new study from Harvard School of ... rates were due to disparities related to both race and ... health and health care are well-documented in this country, but ...
Cached Medicine News:Health News:DMP for coronary heart disease: Current guidelines indicate some need for revision 2Health News:DMP for coronary heart disease: Current guidelines indicate some need for revision 3Health News:Smoking during radiation treatments reduces chance of overall survival 2Health News:Researchers find brain insulin plays critical role in the development of diabetes 2Health News:PSA Test Cut-off Could Signal Low-Risk Prostate Cancer 2Health News:PSA Test Cut-off Could Signal Low-Risk Prostate Cancer 3Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 2Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 3Health News:Study finds blacks more likely to be readmitted to hospitals after discharge 2
The Natural Selection family of specialty allografts are spinal allograft devices to eliminate the need for painful autograft harvesting....
... Corlok Allografts are unique corticocancellous allografts ... and a unique Dovetail geometry permitting ... vertebrae. Corlok Allografts are processed from ... allograft implants. Specially designed instruments facilitate ...
Lumbar Allograft with Osteoactive advantage. Promotes bone formation and faster incorporation. Derived from the proven technology behind Grafton DBM. Maintains structural integrity and strength....
... Anteater Titanium Microdiscectomy System offers strength ... surgery. The boss anteater titanium microdiscectomy ... intervertebral discs provides for less invasive ... retractor is designed to provide low ...
Medicine Products: